A big cannabis market and a big medical program can look like the same kind of success. They measure different things. One counts dollars spent at licensed stores. The other counts people in a medical system, sometimes using a definition that changes from one jurisdiction to the next. For travelers and patients, neither number alone says where a purchase is legal, whether a card is required, or where consumption is allowed.
Oklahoma's Medical Marijuana Authority reported 304,186 patient licenses on October 1, 2026. New Jersey's Cannabis Regulatory Commission reported 42,191 medicinal patients as of October 15, while also publishing separate adult-use sales data. A smaller patient registry does not mean fewer people use legal cannabis there; adults can buy through the recreational market without joining that registry. Oklahoma licensing report · New Jersey program and sales reports
Sales need their own labels. Massachusetts's Cannabis Control Commission reported more than $1.65 billion in adult-use gross sales in 2025. That is a calendar-year retail figure. It should not be ranked against a state's medical-plus-adult-use total, a partial 2026 figure, or an estimate inferred from tax receipts. California illustrates the last distinction: its tax agency publishes cannabis tax revenue and explains the applicable excise-tax rates. Dividing tax receipts by a rate may produce an estimate, but it does not turn that estimate into an agency-reported sales total [1]. Massachusetts Cannabis Control Commission · California tax agency
Even a patient percentage can mislead if the numerator is wrong for the headline. An August D.C. report lists 143,556 total registered D.C. resident patients under program participation. On the same report, 25,005 is the number of unique D.C. resident patients in the month's patient-and-sales section. The first figure is not labeled an active patient count, and the second is a monthly measure. Dividing 143,556 by D.C.'s adult population and calling the result an active-patient rate would overstate what the source establishes [2]. D.C. Alcoholic Beverage and Cannabis Administration, August 2026 report
For Roxy's readers, the useful question comes after the number: what can someone actually do there? A state's sales volume does not grant a visitor the right to buy, carry cannabis across a border, consume in a hotel, or enter a lounge. A medical registry may count residents, visitors, temporary cards, or lifetime registrations differently. Current state program and local venue rules still decide the practical answer.
These figures are useful as examples, not as one national ranking. Dates and definitions need to match before states can be compared fairly [3].
Data notes
[1] California estimate: The supplied 2025 sales figure was derived from tax receipts. It is an estimate, not a state-reported sales total. California Department of Tax and Fee Administration
[2] D.C. patient definition: The agency labels 143,556 as total registered resident patients, not active patients. Its 25,005 figure counts unique patients for August. Neither supports the supplied 25.2% active-patient headline. D.C. program report
[3] Different reporting periods: Some supplied sales figures cover all of 2025; others cover only part of 2026. They should not share a ranked column without aligned periods and sales categories.






